Stereotaxis scores FDA nod for groundbreaking MAGiC robotic heart catheter
The MAGiC catheter is designed for robotically-navigated cardiac ablation procedures
The MAGiC catheter is designed for robotically-navigated cardiac ablation procedures
Elanco expects Befrena to launch in the US in the first half of 2026
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
The Co-Dx PCR platform is designed to deliver gold-standard PCR accuracy in a compact, user-friendly device suitable for decentralized testing environments
The funding will accelerate Sinopia’s data-driven drug discovery efforts
The FDA aims to make a decision by April 8, 2026
HYMPAVZI’s safety profile was generally favorable
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Subscribe To Our Newsletter & Stay Updated